Coronary artery disease—from bench to bedside

Maseri A. From syndromes to specific disease mechanisms. Ital Heart J 2000; 1: 253–7

Lusis A. Atherosclerosis. Nature 2000; 407: 233–41

Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–26

Nicholson AC , Febbraio M , Han J , Silverstein RL , Hajjar DP. CD36 atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci 2000; 90: 128–31

Van Berkel TJ , Van Eck M , Herijgers N , Fluiter K , Nion S. Scavenger receptor classes A and B. Their roles in atherogenesis and the metabolism of modified LDL and HDL. Ann N Y Acad Sci 2000; 902: 113–26

Zingg JM , Ricciarelli R , Azzi A. Scavenger receptor regulation and atherosclerosis. Biofactors 2000; 11: 189–200

Febbraio M , Podrez EA , Smith JD Targeted disruption of class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000; 105: 1049–56

Suzuki H. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386: 292–6

Li AC , Brown KK , Silvestre MJ , Willson TM , Palinski W , Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000; 106: 523–31

Neve BP , Fruchart J , Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol 2000; 60: 1245–50

Bennett MR , Littlewood TD , Schwartz SM , Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 1997; 81: 591–9

Bennett MR , Evan GI , Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995; 95: 2266–74

Mach F , Schonbeck U , Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 1998; 137(suppl): S89–S95

Lutgens E , Cleutjens KB , Heeneman S , Koteliansky VE , Burkly LC , Daemen MJ. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype [see comments]. Proc Natl Acad Sci USA 2000; 97: 7464–9

van der Wal AC , Piek JJ , de Boer OJ Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998; 80: 14–18

Danesh J , Whincup P , Walker M Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000; 321: 208–13

Alber DG , Powell KL , Vallance P , Goodwin DA , Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 2000; 102: 779–85

Danesh J , Whincup P , Walker M Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199–204

Vallance P , Collier J , Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997; 349: 1391–2

Bhagat K , Moss R , Collier J , Vallance P. Endothelial stunning following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 1996; 32: 822–9

Hingorani A , Cross J , Kharbanda R Acute systemic inflammation impairs endothelium-dependant dilatation in humans. Circulation 2000; 102: 994–9

Laitinen M , Hartikainen J , Hiltunen MO Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11: 263–70

Houston P , White BP , Campbell CJ , Braddock M. Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapy. Hum Gene Ther 1999; 10: 3031–44

Fayad ZA , Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci 2000; 902: 173–86

Skinner MP , Yuan C , Mitsumori L Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med 1995; 1: 69–73